STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

AMRX AMNEAL PHARMACEUTICALS StockScouter® Report

5

StockScouter® Score

AMNEAL PHARMACEUTICALS, a small cap value company in the healthcare sector, is expected to perform in line with the market over the next six months with slightly higher than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • The multi-period measure of relative price change and consistency is well above average. Positive
  • The most recent quarterly earnings report was significantly higher than analysts’ consensus forecast. Positive

 

Concerns

  • One or more analysts has significantly decreased quarterly earnings estimates for AMRX. Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that small cap stocks will be neutral, value stocks will be neutral, and healthcare stocks will be neutral.

Expected Risk/Return

Progress: 80% done.
Progress: 60% done.
Low
High

Core Model Grades

A
A
C
A

Previous Ratings

5
4
2